Skip to main content

CORRECTION article

Front. Genet., 22 July 2022
Sec. Computational Genomics
Volume 13 - 2022 | https://doi.org/10.3389/fgene.2022.973325
This article is part of the Research Topic Computational tools in inferring cancer tissue-of-origin and molecular classification towards personalized cancer therapy, Volume III View all 28 articles

Corrigendum: Prognostic ferroptosis-related lncRNA signatures associated with immunotherapy and chemotherapy responses in patients with stomach cancer

This article is a correction to:

  1. Prognostic Ferroptosis-Related lncRNA Signatures Associated With Immunotherapy and Chemotherapy Responses in Patients With Stomach Cancer

    1. Read original article
Donglin Lai,&#x;Donglin Lai1,2†Lin Tan&#x;Lin Tan3†Xiaojia ZuoXiaojia Zuo1DingSheng LiuDingSheng Liu1Deyi JiaoDeyi Jiao4Guoqing WanGuoqing Wan1Changlian LuChanglian Lu1Dongjie Shen Dongjie Shen5*Xuefeng Gu,, Xuefeng Gu1,2,4*
  • 1Shanghai Key Laboratory of Molecular Imaging, Zhoupu Hospital, Shanghai University of Medicine and Health Sciences, Shanghai, China
  • 2School of Health Science and Engineering, University of Shanghai for Science and Technology, Shanghai, China
  • 3The Affiliated Zhuzhou Hospital Xiangya Medical College CSU, Zhuzhou, China
  • 4School of Pharmacy, Shanghai University of Medicine and Health Sciences, Shanghai, China
  • 5Department of General Surgery, Ruijin Hospital Luwan Branch, Shanghai Jiaotong University School of Medicine, Shanghai, China

A Corrigendum on
Prognostic ferroptosis-related lncRNA signatures associated with immunotherapy and chemotherapy responses in patients with stomach cancer

by Lai, D., Tan, L., Zuo, X., Liu, D., Jiao, D., Wan, G., Lu, C., Shen, D., and Gu, X. (2021). Front. Genet. 12:798612. doi: 10.3389/fgene.2021.798612

In the published article, an author name was incorrectly written as Donlin Lai. The correct spelling is Donglin Lai.

The authors apologize for this error and state that this does not change the scientific conclusions of the article in any way. The original article has been updated.

Publisher’s note

All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.

Keywords: stomach cancer, ferroptosis, prognostic, lncRNA, immunotherapy, chemotherapy

Citation: Lai D, Tan L, Zuo X, Liu D, Jiao D, Wan G, Lu C, Shen D and Gu X (2022) Corrigendum: Prognostic ferroptosis-related lncRNA signatures associated with immunotherapy and chemotherapy responses in patients with stomach cancer. Front. Genet. 13:973325. doi: 10.3389/fgene.2022.973325

Received: 20 June 2022; Accepted: 28 June 2022;
Published: 22 July 2022.

Approved by:

Frontiers Editorial Office, Frontiers Media SA, Switzerland

Copyright © 2022 Lai, Tan, Zuo, Liu, Jiao, Wan, Lu, Shen and Gu. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.

*Correspondence: Dongjie Shen, eastheroshen@163.com; Xuefeng Gu, guxf@sumhs.edu.cn

†These authors have contributed equally to this work

Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.